Q: Your thoughts on GUD going forward in light of:
07:20 AM EDT, 03/24/2025 (MT Newswires) -- Knight Therapeutics (GUD.TO) overnight Sunday said G252 Capital has disposed of 2.5 million of its shares at $6.30 each, and no longer holds over 10% of Knight's outstanding shares.
G2S2 now owns 7.54 million Knight shares, for a 7.6% stake.
Does this limit upside of the stock price?
07:20 AM EDT, 03/24/2025 (MT Newswires) -- Knight Therapeutics (GUD.TO) overnight Sunday said G252 Capital has disposed of 2.5 million of its shares at $6.30 each, and no longer holds over 10% of Knight's outstanding shares.
G2S2 now owns 7.54 million Knight shares, for a 7.6% stake.
Does this limit upside of the stock price?
5i Research Answer:
Not necessarily, but investors could fear that G252 will keep selling its remaining shares, and...